DESIGNMEDIX, INC.

Basic Information

2828 Corbett Ave Suite 140A
PORTLAND, OR, 97201-4830

Company Profile

n/a

Additional Details

Field Value
DUNS: 623389009
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Preclinical development of novel small molecule malaria drugs that overcome drug

    Amount: $2,983,056.00

    DESCRIPTION (provided by applicant): The worldwide health problem created by malaria has been made more difficult by the spread of drug- resistant parasites. We have developed an orally available and ...

    STTR Phase II 2014 Department of Health and Human Services
  2. Optimization of a novel antimalarial drug candidate for plant-scale synthesis

    Amount: $102,614.00

    DESCRIPTION (provided by applicant): There is a great need for anti-malarial drugs that are inexpensive and effective against drug-resistant strains. Malaria is one of the most important diseases worl ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Preclinical development of novel small molecule malaria drugs that overcome drug

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The worldwide health problem created by malaria has been made more difficult by the spread of drug- resistant parasites. This project initiates preclinical develop ...

    STTR Phase I 2011 Department of Health and Human Services
  4. Designed Antimalarial Agents Overcoming Chloroquine-Resistance

    Amount: $1,327,608.00

    DESCRIPTION (provided by applicant): DesignMedix has developed a novel class of compounds to address the pressing need for an orally available, inexpensive drug to counter the spread of chloroquine-re ...

    STTR Phase II 2009 Department of Health and Human Services
  5. Designed Antimalarial Agents Overcoming Chloroquine-Resistance

    Amount: $103,876.00

    DESCRIPTION (provided by applicant): The intent of the work presented in this proposal is to counter the worldwide health problem brought on by the spread of chloroquine-resistant malaria. To address ...

    STTR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government